selected publications
-
academic article
- CD40 ligand and risk of ischemic stroke or coronary events in patients with chronic coronary heart disease. International journal of cardiology. 107:322-326. 2006
- Clinical Investigations-Monocyte Chemoattractant Protein-1 and Coronary Disease-Monocyte Chemoattractant Protein-1 and Recurrent Cardiovascular Events in Patients with Stable Coronary Heart. Clinical Cardiology. 28:31-35. 2005
- Chlamydia pneumoniae and future risk in patients with coronary heart disease. International journal of cardiology. 93:25-30. 2004
- Prospective study of Chlamydia pneumoniae IgG and IgA seropositivity and risk of incident ischemic stroke. CEREBROVASCULAR DISEASES. 16:166-170. 2003
- Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease: data from the Bezafibrate Infarction Prevention (BIP) Study. Journal of the American College of Cardiology. 39:1133-1138. 2002
- Soluble intercellular adhesion molecule-1 and risk of future ischemic stroke. STROKE. 33:2182-2186. 2002
- Soluble intercellular adhesion molecule-1 and risk of future ischemic stroke: A nested case-control study from the Bezafibrate Infarction Prevention (BIP) study cohort. STROKE. 33:2182-2186. 2002
-
conference paper
- CD40 ligand concentration and risk of myocardial infarction and ischemic stroke in patients with preexisting atherothrombotic disease. STROKE. 304-304. 2004
- Soluble intercellular adhesion molecule-1 and risk of ischemic stroke: A nested case-control study. STROKE. 358-358. 2002
- Soluble intercellular adhesion molecule 1 level predicts the incidence of myocardial infarction and sudden death in patients with coronary heart disease.. Circulation. 486-486. 2001